Network pharmacology analysis and molecular docking of Phellodendri amurensis cortex in the treatment of Parkinson's disease DOI
Zhaolong He,

Shiqiang Xu,

Xia Chen

et al.

Published: Aug. 13, 2024

Language: Английский

Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders DOI Creative Commons
Duraisamy Kempuraj,

Kirk D. Dourvetakis,

Jessica R. Cohen

et al.

Frontiers in Cellular Neuroscience, Journal Year: 2024, Volume and Issue: 18

Published: Oct. 25, 2024

Neurovascular unit (NVU) inflammation via activation of glial cells and neuronal damage plays a critical role in neurodegenerative diseases. Though the exact mechanism disease pathogenesis is not understood, certain biomarkers provide valuable insight into pathogenesis, severity, progression therapeutic efficacy. These markers can be used to assess pathophysiological status brain including neurons, astrocytes, microglia, oligodendrocytes, specialized microvascular endothelial cells, pericytes, NVU, blood-brain barrier (BBB) disruption. Damage or derangements tight junction (TJ), adherens (AdJ), gap (GJ) components BBB lead increased permeability neuroinflammation various disorders disorders. Thus, neuroinflammatory evaluated blood, cerebrospinal fluid (CSF), tissues determine neurological progression, responsiveness. Chronic common age-related Alzheimer's (AD), Parkinson's (PD), dementia. Neurotrauma/traumatic injury (TBI) also leads acute chronic responses. The expression some may altered many years even decades before onset In this review, we discuss neuroinflammation, neurodegeneration associated with disorders, especially those neurovascular pathologies. CSF, tissues. Neurofilament light (NfL), ubiquitin C-terminal hydrolase-L1 (UCHL1), fibrillary acidic protein (GFAP), Ionized calcium-binding adaptor molecule 1 (Iba-1), transmembrane 119 (TMEM119), aquaporin, endothelin-1, platelet-derived growth factor receptor beta (PDGFRβ) are important markers. Recent BBB-on-a-chip modeling offers promising potential for providing an in-depth understanding neurotherapeutics. Integration these clinical practice could potentially enhance early diagnosis, monitor improve outcomes.

Language: Английский

Citations

5

Glymphatic dysfunction exacerbates cognitive decline by triggering cortical degeneration in Parkinson's disease: evidence from diffusion-tensor MRI. DOI
Yang Zhao,

Changyuan Xu,

Yufan Chen

et al.

PubMed, Journal Year: 2025, Volume and Issue: 7(1), P. fcaf029 - fcaf029

Published: Jan. 1, 2025

The glymphatic system may play a central role in cognitive impairment associated with Parkinson's disease, but its relationship regional cortical atrophy is not fully explored. To explore associations among dysfunction, degeneration and disease participants, we evaluated 51 participants documented (28 men; age, 61.65 ± 8.27 years) 30 age- sex-matched normal controls (11 59.2 5.90 who underwent 3.0-T MRI of the brain, including high-resolution T1-weighted imaging diffusion-tensor along perivascular space as surrogate for flow. Cortical grey matter volume was segmented automatically based on three-dimensional sequences. Cognitive function assessed by Mini-Mental State Examination. between decline revealed lower (1.45 0.17 versus 1.64 0.17, P < 0.0001) compared controls, indicating disturbed Glymphatic dysfunction scores (r = 0.54, 0.003). Diffusion-tensor values were positively specific regions (all P-values <0.05) temporal pole, posterior orbital gyrus, part inferior frontal operculum, operculum anterior cingulate gyrus. Mediation analysis within indicated that partially mediated integrity gyrus whereas distribution constitute link impairment.

Language: Английский

Citations

0

OAB-14 Attenuated Glymphatic System Disorder, Neuroinflammation and Dyskinesia in Parkinson’s Disease Model Mice Induced by Rotenone DOI
Xinyu Zhao,

Ruolin Cao,

Xiaoyi Tian

et al.

Neurochemical Research, Journal Year: 2025, Volume and Issue: 50(2)

Published: April 1, 2025

Language: Английский

Citations

0

Clinical and brain volumetric correlates of decreased DTI-ALPS, suggestive of local glymphatic dysfunction, in iRBD DOI Creative Commons
Ignacio Roura, Jèssica Pardo, Cristina Martín‐Barceló

et al.

npj Parkinson s Disease, Journal Year: 2025, Volume and Issue: 11(1)

Published: April 23, 2025

Language: Английский

Citations

0

The role of the gut microbiome and brain-liver-gut Axis in neurological disorders DOI Creative Commons
Pan Li,

Lizheng Xie,

W.-C. Yang

et al.

Burns & Trauma, Journal Year: 2025, Volume and Issue: 13

Published: Jan. 1, 2025

Abstract In recent years, with the increasing volume of related research, it has become apparent that liver and gut play important roles in pathogenesis neurological disorders. Considering interactions among brain, liver, gut, brain–liver–gut axis been proposed gradually recognized. this article, we summarized complex network within axis, encompassing vagus nerve, barrier permeability, immunity inflammation, blood–brain barrier, microbial metabolites, neurotoxic beta-amyloid (Aβ) metabolism. We also elaborated on impact various Furthermore, outline several therapies aimed at modulating including antibiotics, probiotics prebiotics, fecal microbiota transplantation (FMT), nerve stimulation (VNS), dietary interventions. The focus is elucidating possible mechanisms underlying disorders identifying effective treatments are based our understanding axis.

Language: Английский

Citations

0

Intranasal Administration of GRP78 Protein (HSPA5) Counteracts the Neurodegeneration in the Locus Coeruleus in a Model of Chronic Sleep Restriction in Rats DOI
М. Б. Пази, И. В. Екимова

Journal of Evolutionary Biochemistry and Physiology, Journal Year: 2024, Volume and Issue: 60(4), P. 1630 - 1641

Published: July 1, 2024

Language: Английский

Citations

0

Intranasal administration of GRP78 protein (HSPA5) counteracts the neurodegeneration in the locus coeruleus in a model of chronic sleep restriction in rats DOI
М. Б. Пази, И. В. Екимова

Российский физиологический журнал им  И  М  Сеченова, Journal Year: 2024, Volume and Issue: 110(8), P. 1238 - 1252

Published: Oct. 19, 2024

Chronic sleep restriction (sleep less than 6 hours per day) due to the workload and a decrease in quality is an endemic disease modern society. deprivation causes serious neuropsychiatric disorders associated with irreversible neurodegenerative changes brain. The search for pharmacological agents that can reduce risk of neurodegeneration as result chronic loss urgent task issue biomedicine. Intranasal administration glucose-regulated 78 kDa heat shock protein (GRP78) has neuroprotective effect rat model Parkinson´s disease. potential intranasally administered GRP78 not been previously studied. aim study find out whether preventive intranasal able weaken and/or stop process locus coeruleus (SR) rats. was conducted on months old male Wistar For deprivation, validated method swinging platform used mode: 3 1 hour rest continuously 5 days. Recombinant human two days before start SR during SR. Cellular molecular were studied using immunohistochemistry Western blotting. It shown leads degeneration 30% noradrenergic neurons coeruleus, increase levels activated caspases-3 9. This indicates development apoptosis along mitochondrial pathway. No signs reactive microgliosis found We have demonstrated penetrates accumulates counteracts death path apoptosis. data obtained allows consider agent prevention pathological consequences deprivation.

Language: Английский

Citations

0

Intranasal administration of tissue inhibitor of metalloproteinase 1 extracted from stem cells from human exfoliated deciduous teeth-conditioned medium improves neurological outcomes and alpha-synuclein elimination in Parkinson's disease mice DOI Creative Commons

Yi-No Chen,

Yong-Ren Chen,

Bing-Heng Yang

et al.

Journal of Dental Sciences, Journal Year: 2024, Volume and Issue: 20(2), P. 1043 - 1051

Published: Dec. 12, 2024

Parkinson's disease (PD) remains a challenging neurodegenerative disorder, requiring the exploration of innovative therapeutic strategies. This study assessed neuroprotective effects stem cells from human exfoliated deciduous teeth-conditioned medium (SHED-CM) in rotenone-induced mouse model PD. The SHED-CM, fractionated and purified via Fast Protein Liquid Chromatography (FPLC) into "yPD01", was administered intranasally to evaluate its impact on motor deficits, olfactory functions, protein expressions affected brain regions. Upon intranasal delivery, yPD01 produced significant improvements deficits restoration associated with PD pathology, particularly bulb substantial nigra. Intriguingly, route exhibited efficacy akin intravenous administration, highlighting potential as minimally invasive yet equally effective approach. Further investigation indicated key components within yPD01, denoted peaks P1 P5, showcasing pivotal effects. These were linked interruption alpha-synuclein aggregation clearance specific by Intranasally shows for mitigating symptoms, results provide valuable insights mechanisms underlying SHED-CM their implications future interventions related conditions.

Language: Английский

Citations

0

Network pharmacology analysis and molecular docking of Phellodendri amurensis cortex in the treatment of Parkinson's disease DOI
Zhaolong He,

Shiqiang Xu,

Xia Chen

et al.

Published: Aug. 13, 2024

Language: Английский

Citations

0